Abstract
Hydroxyurea (HU) is an effective but underused disease-modifying therapy for patients with sickle cell anaemia (SCA). EMBRACE SCD, a sickle cell disease treatment demonstration project, aimed to improve access to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have